Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 10, 2021 17:15 ET | Source: Predictive Oncology Inc.

Predictive Oncology Reports Third Quarter Financial Results

EAGAN, Minn., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Results from the third quarter show strong potential for future growth, said Predictive Oncology (Nasdaq: POAI) today, announcing financial results...
October 19, 2021 08:30 ET | Source: Predictive Oncology Inc.

Predictive Oncology Launches Website Highlighting AI-Powered Cancer Research Advancements

MINNEAPOLIS, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology, an oncology and cancer research company using big data and machine learning to improve pharmaceutical development and predictive...
September 15, 2021 08:30 ET | Source: Predictive Oncology Inc.

Predictive Oncology Inc. Announces Newest Board Member

MINNEAPOLIS, Sept. 15, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug...
August 18, 2021 13:45 ET | Source: Predictive Oncology Inc.

Predictive Oncology Announces Results of Charter Amendment Proposal at Special Meeting

MINNEAPOLIS, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug...
August 11, 2021 17:15 ET | Source: Predictive Oncology Inc.

Predictive Oncology Reports Financial Results for Quarter Ended June 30, 2021, and Provides Business Update

MINNEAPOLIS, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug...
August 11, 2021 08:30 ET | Source: Predictive Oncology Inc.

Predictive Oncology Adjourns Special Meeting of Stockholders

MINNEAPOLIS, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug...
August 03, 2021 08:30 ET | Source: Predictive Oncology Inc.

Predictive Oncology subsidiary, Helomics uses data from the 100,000 Genomes Project to better predict ovarian cancer outcomes

MINNEAPOLIS, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug...
June 22, 2021 08:30 ET | Source: Predictive Oncology Inc.

Predictive Oncology Inc.’s Subsidiaries Soluble Biotech Inc. and TumorGenesis Inc. are both constructing new GMP labs

MINNEAPOLIS, June 22, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), an AI-driven oncology and drug discovery company, announced today that two of their wholly owned subsidiaries,...
June 18, 2021 09:30 ET | Source: Predictive Oncology Inc.

Predictive Oncology Announces Closing of $21.34 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

MINNEAPOLIS, June 18, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial...
June 14, 2021 09:30 ET | Source: Predictive Oncology Inc.

Predictive Oncology Announces $21.34 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

MINNEAPOLIS, June 14, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial...